NumerixS Investment Technologies’s Emergent Biosolutions EBS Stock Holding History

NumerixS Investment Technologies’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-501	Closed	-$40K	–	251
2020 Q2	$40K	Sell	501 -1,900	-79%	-$142K	0.01%	837
2020 Q1	$139K	Buy	+2,401	New	+$138K	0.07%	337
2019 Q4	–	Sell	-200	Closed	-$10K	–	1095
2019 Q3	$10K	Buy	+200	New	+$9.32K	﹤0.01%	938
2018 Q4	–	Sell	-1,700	Closed	-$112K	–	1156
2018 Q3	$112K	Buy	1,700 +400	+31%	+$23.3K	0.02%	774
2018 Q2	$66K	Buy	+1,300	New	+$67.7K	0.02%	861
2017 Q1	–	Sell	-5,900	Closed	-$194K	–	1200
2016 Q4	$194K	Buy	+5,900	New	+$177K	0.02%	678
2016 Q3	–	Sell	-11,000	Closed	-$309K	–	1164
2016 Q2	$309K	Buy	+11,000	New	+$431K	0.04%	556

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

NumerixS Investment Technologies's EBS Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Emergent Biosolutions (EBS) in Q3 2020, closing a stake of 501 shares — an estimated $40K sold.

NumerixS Investment Technologies first reported a position in EBS in Q2 2016 and held it in 7 quarters. The position peaked at $309K in Q2 2016. 358 funds tracked by Wall St. Rank hold EBS as of Q3 2020.

NumerixS Investment Technologies reported no remaining Emergent Biosolutions position as of Q3 2020 after selling out during the quarter.
NumerixS Investment Technologies sold 501 Emergent Biosolutions shares in Q3 2020, an estimated $40K.
NumerixS Investment Technologies first reported a position in Emergent Biosolutions in Q2 2016 and held it in 7 quarters.
NumerixS Investment Technologies's Emergent Biosolutions position peaked at $309K in Q2 2016.
358 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.